Proteoglycan compositions for treating arthritic inflammatory conditions
OwnerTheoharis C. Theoharidesinventor
Life of this patent
Estimating the term…
Abstract
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of a heavily sulfated, non-bovine proteoglycan such as shark cartilage chondroitin sulfate C, and one or more of a hexosamine sulfate such as D-glucosamine sulfate, a flavone such as quercetin, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, caffeine, and a polyamine.
Claims1
A composition with synergistic anti-inflammatory properties in arthritic conditions induced by the activation of mast cells, consequent degranulation of said cells and subsequent secretion of inflammatory biomolecules, comprising:
- shark cartilage chondroitin sulfate, 150 mg;
- Saphona plant quercetin, 150 mg;
- shellfish chitin D-glucosamine sulfate;
- unrefined, microfiltered olive kernel (pit) extract of acidity less than about 3% and water less than about 5%, 55%;
- and, as suspending agents, 40 mg beeswax and 20 mg lecithin, in soft gel capsules made from pig gelatin.
Dependencies are inferred from the claim text.